Using a new, powerful method for rapidly screening molecules associated with disease, proteomics experts have identified a broad panel of 28 early predictors, or biomarkers, that may one day aid in the early diagnosis of breast cancer.
Using a new, powerful method for rapidly screening molecules associated with disease, proteomics experts have identified a broad panel of 28 early predictors, or biomarkers, that may one day aid in the early diagnosis of breast cancer.